Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

Too many people are missing out on a potentially life-changing opportunity to prevent cancer,” said Sir John Burn.

CHICAGO — Daily adjuvant aspirin did not reduce disease recurrence for patients with colorectal cancer liver metastases and may increase risk for death, according to findings presented at ASCO ...

A groundbreaking new study reveals that a simple, low-dose aspirin—already found in millions of homes—can slash the risk of ...

Conclusions: This phase 3 trial showed that in patients with colorectal cancer liver metastasis, daily aspirin 160 mg after complete tumor removal did not improve disease-free or overall survival.

Prof Sir John Burn, from Newcastle University, said he would ask health regulators to formally advise a low dose of 75mg be ...

Can aspirin prevent colorectal cancer? Two large randomized primary prevention trials showed no effect after 10 years of follow-up (Journal Watch May 8 1998 and Aug 2 2005), but perhaps this time ...

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Electra D. Paskett, PhD, MSPH, FACE, FAACR, was elected as a fellow to the American Association for Cancer Research Academy ...